Literature DB >> 27889469

Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson's disease.

Janina Borgonovo1, Camilo Allende-Castro1, Almudena Laliena2, Néstor Guerrero2, Hernán Silva3, Miguel L Concha4.   

Abstract

Although Parkinson's Disease (PD) is mostly considered a motor disorder, it can present at early stages as a non-motor pathology. Among the non-motor clinical manifestations, depression shows a high prevalence and can be one of the first clinical signs to appear, even a decade before the onset of motor symptoms. Here, we review the evidence of early dysfunction in neural circuitry associated with depression in the context of PD, focusing on pre-clinical, pre-motor and early motor phases of the disease. In the pre-clinical phase, structural and functional changes in the substantia nigra, basal ganglia and limbic structures are already observed. Some of these changes are linked to motor compensation mechanisms while others correspond to pathological processes common to PD and depression and thus could underlie the appearance of depressive symptoms during the pre-motor phase. Studies of the early motor phase (less than five years post diagnosis) reveal an association between the extent of damage in different monoaminergic systems and the appearance of emotional disorders. We propose that the limbic loop of the basal ganglia and the lateral habenula play key roles in the early genesis of depression in PD. Alterations in the neural circuitry linked with emotional control might be sensitive markers of the ongoing neurodegenerative process and thus may serve to facilitate an early diagnosis of this disease. To take advantage of this, we need to improve the clinical criteria and develop biomarkers to identify depression, which could be used to determine individuals at risk to develop PD.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Depression; Early motor stage; Limbic loop; Parkinson; Pre-clinical; Pre-motor

Mesh:

Year:  2016        PMID: 27889469     DOI: 10.1016/j.parkreldis.2016.11.009

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  16 in total

1.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

Review 2.  Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

Authors:  Luigi Trojano; Costanza Papagno
Journal:  Neurol Sci       Date:  2017-10-16       Impact factor: 3.307

Review 3.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

Review 4.  Inflammatory markers and depression in Parkinson's disease: a systematic review.

Authors:  Luis Guilherme Ramanzini; Luís Fernando Muniz Camargo; Juliana Oliveira Freitas Silveira; Guilherme Vargas Bochi
Journal:  Neurol Sci       Date:  2022-08-30       Impact factor: 3.830

Review 5.  Parkinson and depression: review and outlook.

Authors:  Gerd Laux
Journal:  J Neural Transm (Vienna)       Date:  2022-01-04       Impact factor: 3.850

6.  Psychological Stress Phenocopies Brain Mitochondrial Dysfunction and Motor Deficits as Observed in a Parkinsonian Rat Model.

Authors:  Mariana Grigoruţă; Alejandro Martínez-Martínez; Raul Y Dagda; Ruben K Dagda
Journal:  Mol Neurobiol       Date:  2019-12-14       Impact factor: 5.590

Review 7.  Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.

Authors:  Anne-Claire Dupont; Bérenger Largeau; Maria Joao Santiago Ribeiro; Denis Guilloteau; Claire Tronel; Nicolas Arlicot
Journal:  Int J Mol Sci       Date:  2017-04-07       Impact factor: 5.923

8.  Differential microstructural alterations in rat cerebral cortex in a model of chronic mild stress depression.

Authors:  Ahmad Raza Khan; Christopher D Kroenke; Ove Wiborg; Andrey Chuhutin; Jens R Nyengaard; Brian Hansen; Sune Nørhøj Jespersen
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

Review 9.  Early Life Stress, Depression And Parkinson's Disease: A New Approach.

Authors:  Ernest Dallé; Musa V Mabandla
Journal:  Mol Brain       Date:  2018-03-19       Impact factor: 4.041

Review 10.  Diagnostic biomarkers for Parkinson's disease at a glance: where are we?

Authors:  Ilaria Cova; Alberto Priori
Journal:  J Neural Transm (Vienna)       Date:  2018-08-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.